.
Biotransform project announces doctoral and researcher vacancies across partner institutions
For PhD Students
Research
From 1 November 2025 to 31 October 2029, Rīga Stradiņš University (RSU) is partnering with leading universities and research institutes with expertise spanning clinical research, pharmacology, metabolite profiling, microbiome science, colon simulation models and translational biopharmaceutics, including NKUA-Med, NKUA-Pharm, MedUniGraz, UGraz, Teagasc, UCC, UAntwerp, UBath, ICL, to implement the Biotransform project.
Applications are now open for four doctoral candidate (DC) vacancies within the framework of the project:
- DC1 open position in Antwerp, Belgium
- DC2 open position in Antwerp, Belgium
- DC7 open position in Cork, Ireland
- DC11 open position at the Latvian Institute of Organic Synthesis (LIOS), Latvia
RSU will be hiring a doctoral student for the eighth phase of the project (DC8 open position).
The application period is open from 1 February to 31 March 2026. The expected start date is 1 July 2026.
Read more about the Biotransform project and the open positions on the Biotransform website.
Related news
RSU presents results of project on patient-reported outcome measures in breast cancer patientsResearch From environment to body: first human biomonitoring study in Latvia reveals main sources of pollution Research
RSU completes study on public perception of media and journalism in Latvia and Estonia Internal consolidation, Research
